AiCuris is a clinical-stage biopharmaceutical company focused on resistance breaking antiviral and antibacterial therapeutics targeting Human Cytomegalovirus, Herpes simplex, HIV, Hepatitis B and C and multi-resistant bacteria. AiCuris‘ mission is the development of innovative drugs against severe and life-threatening infectious diseases with high medical need. AiCuris aims to be THE successful innovator for antiviral and antibacterial therapy.

Schering AG was a research-centered German multinational pharmaceutical company headquartered in Wedding, Berlin, which operated as an independent company from 1851 to 2006. In 2006 it was bought by Bayer AG and merged to form the Bayer subsidiary Bayer Schering Pharma AG, which was renamed Bayer HealthCare Pharmaceuticals in 2011. Schering was listed on the Frankfurt Stock Exchange and had 26,000 employees as of 2004.

Shandong Yangcheng Biotechnology Co., Ltd., established on 2009-01-14, Business scope includes food(L-Tyrosine,gamma-GABA,beta-Alanine,N-Acetyl-L-Tyrosine,D-Aspartic acid,DL-Aspartic acid,D-Phenyllactic acid,Levodopa,caffeic acid,vegetable protein liquid,Hydroxytyrosol,p-Hydroxyphenylacetic acid,calcium propionate)production,Sales;Pharmaceutical Intermediates(L-Tyrosine,beta-Alanine,D-Aspartic acid,DL-Aspartic acid,Tyramine,Tyramine hydrochloride,Levodopa,dopamine,L-pyroglutamic acid,D-pyroglutamic acid,D-Phenyllactic acid,D-glutamic acid,D-Tryptophan,Tryptamine,indole acetic acid,butyric acid,Tyrosol,Hydroxytyrosol,Danshensu,caffeic acid,trans-para-hydroxycinnamic acid,trans cinnamic acid,butyronic acid,Methyl triazole carboxylate,2-GABA,Phenylacetic acid)production,Sales;Feed additives(gamma-GABA,L-Tyrosine,N-Acetyl-L-Tyrosine,D-Phenyllactic acid,D-thbrthdrexvbdr)production,Sales;fertilizer(Water soluble fertilizer)production,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ.

Jiangsu Chengxin Pharmaceutical Co. Ltd. engages in pharmaceutical preparations. The firm offers cosmetic, pharmaceutical, supplements, and coenzyme Ingredients. Its products include Praziquantel, Nicotinamide Mononucleotide, Nicotinamide Adenine Dinucleotide, reduced Nicotinamide Adenine Dinucleotide and Alanyl Glutamine. The company is headquartered in Nantong, China.

Behringwerke AG, a subsidiary of Sanofi, is a German company located in Marburg. The firm produces specialty chemicals and pharmaceutical products.

Nanogen, Inc., a diagnostics company, engages in developing, manufacturing, and selling diagnostic products for use in the in vitro diagnostic market in the United States, Canada, and Europe. It offers diagnostic test kits and reagents based on polymerase chain reaction (PCR) technology in the molecular diagnostic market. The company’s PCR molecular product lines comprise Q-PCR Alert products for in-vitro diagnostic use, and are sold in Italy via a contract sales force and in other European countries through a network of distributors; and MGB Alert products. It also offers point-of-care products, which include qualitative cardiac test products that are rapid test assays used in emergency care settings for the diagnosis of myocardial infarction; quantitative cardiac tests, a quantitative test measuring the concentration of the peptide NT-proBNP for the diagnosis of congestive heart failure; and pandemic influenza test that detects and differentiates the various strains of influenza, including potential pandemic strains. The company was founded in 1993 and is headquartered in San Diego, California. On May 13, 2009, Nanogen, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the District of Delaware.

Taxus Cardium Pharmaceuticals Group, Inc. is regenerative therapeutics company. The company focuses on the late-stage clinical and development of regenerative medicine therapeutics. Its product candidates include Generx, an interventional cardiology, angiogenic gene therapy product candidate designed for the treatment of cardiac microvascular insufficiency due to increasing coronary artery disease, and Excellagen, an acellular biological skin substitute designed as a wound care product for the treatment of chronic non-healing diabetic foot, venous and pressure ulcers. The company was founded by Christopher J. Reinhard and Tyler M. Dylan-Hyde in December 2003 and is headquartered in San Diego, CA.

Viterra Inc. was a Canadian grain handling business, the nation's largest grain handler, with its historic formative roots in prairie grain-handling cooperatives, among them the iconic Saskatchewan Wheat Pool. Viterra Inc grew into a global agri-business with operations in Canada, the United States, Australia, New Zealand and China. Viterra operated three distinct, inter-related businesses: Grain Handling & Marketing, Agri-Products and Processing, enabling it to generate earnings at various points on the food production chain from field to the table. Following its $6.1-billion acquisition by Glencore International, on 1 January 2013 Viterra Inc was merged with Glencore purchaser, 8115222 Canada Inc.

US Agriculture LLC provides investment services. It operates and manage farmland assets and portfolios, develop and implement farmland investment strategies, underwrite and acquire farmland assets across a variety of regions and crop types, develop and implement efficient and effective reporting processes, design and implement investment policies, develop and implement asset allocation strategies, create and implement tools for market and asset targeting, and create and implement portfolio optimization tools and processes. The company was founded in 2015 and is headquartered in Indianapolis, IN.

Gamida for Life BV is an Israeli private company headquartered in Petach Tikva that operates in several countries and invests in the healthcare industry.

Zhongshan Junkai Biotechnology Development Co., Ltd., established on 2019-07-18, Business scope includes biotechnology extension services;research and development:Biological product,Specialty Chemicals(Free of Hazardous Chemicals).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Beijing Academy of Agriculture & Forestry Sciences is a Chinese private company with domestic subsidiaries, that operates as an agricultural research organization.

Zhejiang Yongtai Technology Co., Ltd. engages in the production, research, development, sale, and service of medicines, pesticides, electronic chemicals, and new energy lithium battery materials. Its products include active pharmaceutical ingredients (APIs), pharmaceutical intermediates, advanced intermediates, basic intermediates, pesticides, liquid crystal materials, and lithium battery materials. It also provides contract manufacturing services. The company was founded by Ying Mei Wang and Ren Bao He on October 11, 1999 and is headquartered in Taizhou, China.

Zhejiang Yongtai Pharmaceutical Co., Ltd., established on 2012-07-13, Business scope includes pharmaceutical manufacturing,Import and export of goods and technology.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

BASF AB supplies raw materials to paper, chemicals, and construction industries. Its products include construction chemical, crop protection products, dispersions and pigments, plastics, polyurethane systems and coating products. The company was founded in 1953 and is headquartered in Göteborg, Sweden.

Develops and manufactures drugs related to immunology, neurobiology and oncology

Xukang Medical Technology (Suzhou) Co., Ltd., established on 2015-04-03, Business scope includes technological development of medical technology and biotechnology,Technology Promotion,technical consulting,Technical Services,technology transfer;genetic analysis,Health Management Consulting;Research and development of biological reagents;Sales of biological reagents for laboratory use;Production and sales of medical supplies and equipment;Sales of laboratory equipment;computer software development;computer,Sales of software and auxiliary equipment;Self-operated and agent import and export business of various commodities and technologies(Excluding commodity technologies that are restricted by the state to be operated by enterprises or prohibited from import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)